Clinical Trial Update: ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating ITI with SCT800 alone or in combination with daratumumab in adolescents and adults with Hemophilia A and high-titer inhibitors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitor

Drugs mentioned

• Daratumumab (daratumumab)
• SCT800

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia A With Inhibitor | Phase 4 | Status: RECRUITING